Marshall Wace
CDNA icon

Marshall Wace’s CareDx CDNA Stock Holding History

Marshall Wace’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$510K Buy
+17,898
New +$390K ﹤0.01% 2512
2025
Q2 		– Sell
-43,872
Closed -$779K – 2743
2025
Q1 		$779K Sell
43,872
-245,585
-85% -$5.29M ﹤0.01% 1889
2024
Q4 		$6.2M Sell
289,457
-78,973
-21% -$1.92M 0.01% 970
2024
Q3 		$11.5M Buy
368,430
+312,719
+561% +$7.78M 0.01% 713
2024
Q2 		$865K Sell
55,711
-211,002
-79% -$2.55M ﹤0.01% 1754
2024
Q1 		$2.82M Buy
266,713
+221,451
+489% +$2.22M ﹤0.01% 1223
2023
Q4 		$543K Buy
45,262
+11,884
+36% +$97.4K ﹤0.01% 1696
2023
Q3 		$234K Sell
33,378
-118,466
-78% -$1.09M ﹤0.01% 1946
2023
Q2 		$1.29M Sell
151,844
-487,413
-76% -$4.06M ﹤0.01% 1615
2023
Q1 		$5.84M Buy
+639,257
New +$8.18M 0.01% 917
2022
Q1 		– Sell
-1,284
Closed -$58K – 3403
2021
Q4 		$58K Sell
1,284
-3,889
-75% -$203K ﹤0.01% 3529
2021
Q3 		$328K Buy
5,173
+2,377
+85% +$181K ﹤0.01% 2603
2021
Q2 		$256K Sell
2,796
-36,005
-93% -$2.86M ﹤0.01% 2374
2021
Q1 		$2.64M Buy
+38,801
New +$3.01M 0.01% 1172
2020
Q4 		– Sell
-7,176
Closed -$273K – 1903
2020
Q3 		$273K Buy
+7,176
New +$242K ﹤0.01% 1391
2020
Q1 		– Sell
-23,001
Closed -$496K – 1656
2019
Q4 		$496K Buy
+23,001
New +$528K ﹤0.01% 1176
2019
Q3 		– Sell
-6,967
Closed -$250K – 1686
2019
Q2 		$250K Buy
+6,967
New +$223K ﹤0.01% 1212
2019
Q1 		– Sell
-55,918
Closed -$1.41M – 1743
2018
Q4 		$1.41M Buy
+55,918
New +$1.44M 0.01% 816

Other funds holding CDNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marshall Wace's CDNA Position: Q2 2026 in Review

Marshall Wace opened a new position in CareDx (CDNA) in Q2 2026: 17,898 shares worth $510K. The stake represents ﹤0.01% of the portfolio and ranks #2512 among its holdings. This is a return to the name: Marshall Wace previously reported a position in CDNA as recently as Q1 2025.

Marshall Wace first reported a position in CDNA in Q4 2018 and has held it in 18 quarters since. The position peaked at $11.5M in Q3 2024. 228 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Marshall Wace held 17,898 shares of CareDx worth $510K as of Q2 2026.
  • CareDx was a new Marshall Wace position in Q2 2026.
  • CareDx made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #2512 holding.
  • Marshall Wace first reported a position in CareDx in Q4 2018 and has held it in 18 quarters since.
  • Marshall Wace's CareDx position peaked at $11.5M in Q3 2024.
  • 228 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.